Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Consulting agrmnt
Director departure
Asset disposition
Auditor change
Acq. announced
Appointed director
Filed Chapter 11
Aspira Women's Health Inc. (VRML) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
08/14/2023 8-K/A Quarterly results
Docs: "Exhibit 99.1 Aspira Women’s Health® Reports Second Quarter 2023 Financial Results Continued growth trend with second quarter revenue of $2.5 million, an increase of 23% over the second quarter of 2022."
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
08/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/24/2023 8-K Quarterly results
07/24/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/20/2023 8-K Quarterly results
07/14/2023 8-K Quarterly results
06/28/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
06/02/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EMPLOYMENT AGREEMENT"
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ASPIRA WOMEN’S HEALTH INC."
05/11/2023 8-K Quarterly results
Docs: "Exhibit 99.1 First Quarter total product revenue of $2.3 million, an increase of 26% year-over-year First Quarter OvaSuite volume of 6,259 units, an increase of 29% year-over-year"
05/10/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/28/2023 8-K Preliminary quarterly results
04/04/2023 ARS Form ARS - Annual Report to Security Holders:
03/30/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/30/2023 10-K Annual Report for the period ended December 31, 2022
03/30/2023 8-K Quarterly results
03/29/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/22/2023 8-K Quarterly results
Docs: "Exhibit 99.1"
03/20/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
03/02/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT"
02/10/2023 8-K Quarterly results
02/10/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
02/07/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ASPIRA WOMEN’S HEALTH INC."
01/10/2023 8-K/A Investor presentation
01/10/2023 8-K Investor presentation
01/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Aspira Women’s Health Announces Preliminary Fourth Quarter 2022 Volume, Achievement of Cash Utilization Guidance, and Other Highlights Preliminary fourth quarter 2022 volume was 5,643 tests, an increase of 18% compared to last year"
12/28/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/28/2022 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy